Conventionally, macrophages are divided into two major groups CD14+ S100A8/9+ M1-like (classical macrophages) having anti-tumor functions and CD16+(FCGR3A) M2-like (alternate macrophages) with pro-tumorigenic phenotypes (86). Here, FCGR3A is linked to neoplasm.